Lecanemab for Alzheimer’s Disease: A New Hope to Slow Memory Loss

Learn more about lecanemab, a new, FDA-approved medication to slow Alzheimer’s disease. Dr. Michael Rosenbloom, a behavioral neurologist at UW Medicine's Memory & Brain Wellness Center in Seattle explains how the drug works.

Chapters:
0:00 Alzheimer’s in America
0:20 Lecanemab and who it’s for
0:30 Dr. Michael Rosenbloom
0:59 How lecanemab works
1:23 How to qualify for treatment

Right as Rain is dedicated to helping you feel healthy and well – the Pacific Northwest way. Our medical experts work for UW Medicine in Seattle.

Subscribe to our newsletter for health and wellness tips: https://rightasrain.uwmedicine.org/

Follow Right as Rain on social media:
Instagram ➡️   / berightasrain  
Facebook ➡️   / berightasrain  
Pinterest ➡️   / berightasrain